Correlation Between Okta and TTY Biopharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Okta and TTY Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and TTY Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and TTY Biopharm Co, you can compare the effects of market volatilities on Okta and TTY Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of TTY Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and TTY Biopharm.

Diversification Opportunities for Okta and TTY Biopharm

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Okta and TTY is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and TTY Biopharm Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TTY Biopharm and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with TTY Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TTY Biopharm has no effect on the direction of Okta i.e., Okta and TTY Biopharm go up and down completely randomly.

Pair Corralation between Okta and TTY Biopharm

Given the investment horizon of 90 days Okta Inc is expected to generate 3.76 times more return on investment than TTY Biopharm. However, Okta is 3.76 times more volatile than TTY Biopharm Co. It trades about 0.1 of its potential returns per unit of risk. TTY Biopharm Co is currently generating about 0.07 per unit of risk. If you would invest  7,381  in Okta Inc on August 30, 2024 and sell it today you would earn a total of  261.00  from holding Okta Inc or generate 3.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Okta Inc  vs.  TTY Biopharm Co

 Performance 
       Timeline  
Okta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Okta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Okta is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
TTY Biopharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TTY Biopharm Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, TTY Biopharm is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Okta and TTY Biopharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Okta and TTY Biopharm

The main advantage of trading using opposite Okta and TTY Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, TTY Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTY Biopharm will offset losses from the drop in TTY Biopharm's long position.
The idea behind Okta Inc and TTY Biopharm Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings